Patients younger than 40 years with colorectal cancer have a similar prognosis to older patients

Patients younger than 40 years with colorectal cancer have a similar prognosis to older patients

Purpose Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. In recent years, the proportion of patients diagnosed with CRC at younger ages has increased. The clinicopathological features and oncological outcomes in younger patients with CRC remain controversial. We aimed t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of colorectal disease 2023-07, Vol.38 (1), p.191-191, Article 191
Hauptverfasser: Abe, Tomoki, Matsuda, Takeru, Sawada, Ryuichiro, Hasegawa, Hiroshi, Yamashita, Kimihiro, Kato, Takashi, Harada, Hitoshi, Urakawa, Naoki, Goto, Hironobu, Kanaji, Shingo, Oshikiri, Taro, Kakeji, Yoshihiro
Format: Artikel
Sprache:eng
Schlagworte:
Adjuvant treatment
Adult
Age Factors
Aged
Aged patients
Aged, 80 and over
Analysis
Cancer
Chemotherapy, Adjuvant
Colon, Transverse
Colorectal cancer
Colorectal Neoplasms - mortality
Colorectal Neoplasms - therapy
Female
Gastroenterology
Hepatology
Humans
Internal Medicine
Japan - epidemiology
Male
Medical colleges
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Middle Aged
Neoadjuvant Therapy
Postoperative Complications
Proctology
Prognosis
Surgery
Survival Rate
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. In recent years, the proportion of patients diagnosed with CRC at younger ages has increased. The clinicopathological features and oncological outcomes in younger patients with CRC remain controversial. We aimed to analyze the clinicopathological features and oncological outcomes in younger patients with CRC. Methods We examined 980 patients who underwent surgery for primary colorectal adenocarcinoma between 2006 and 2020. Patients were divided into two cohorts: younger (
ISSN:1432-1262
0179-1958
1432-1262
DOI:10.1007/s00384-023-04488-5